ATE298580T1 - Eigenschaften von poly(amidoamine) dendrimeren als adjuvantien - Google Patents
Eigenschaften von poly(amidoamine) dendrimeren als adjuvantienInfo
- Publication number
- ATE298580T1 ATE298580T1 AT97904184T AT97904184T ATE298580T1 AT E298580 T1 ATE298580 T1 AT E298580T1 AT 97904184 T AT97904184 T AT 97904184T AT 97904184 T AT97904184 T AT 97904184T AT E298580 T1 ATE298580 T1 AT E298580T1
- Authority
- AT
- Austria
- Prior art keywords
- dendrimers
- amidoamine
- poly
- adjuvants
- properties
- Prior art date
Links
- 229920000962 poly(amidoamine) Polymers 0.000 title abstract 4
- 239000002671 adjuvant Substances 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 239000000412 dendrimer Substances 0.000 abstract 1
- 229920000736 dendritic polymer Polymers 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
- A61K2039/645—Dendrimers; Multiple antigen peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/16—Dendrimers and dendritic polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/597,938 US5795582A (en) | 1996-02-07 | 1996-02-07 | Adjuvant properties of poly (amidoamine) dendrimers |
| PCT/US1997/001664 WO1997028809A1 (en) | 1996-02-07 | 1997-02-06 | Adjuvant properties of poly(amidoamine) dendrimers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE298580T1 true ATE298580T1 (de) | 2005-07-15 |
Family
ID=24393563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97904184T ATE298580T1 (de) | 1996-02-07 | 1997-02-06 | Eigenschaften von poly(amidoamine) dendrimeren als adjuvantien |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5795582A (de) |
| EP (1) | EP0914134B1 (de) |
| JP (1) | JP2000507921A (de) |
| AT (1) | ATE298580T1 (de) |
| AU (1) | AU1854197A (de) |
| CA (1) | CA2249544A1 (de) |
| DE (1) | DE69733652D1 (de) |
| WO (1) | WO1997028809A1 (de) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387373B1 (en) * | 1993-01-15 | 2002-05-14 | Novavax, Inc. | Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants |
| EP0884327B1 (de) * | 1997-06-11 | 2001-03-14 | The School Of Pharmacy, University Of London | Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung |
| AT408615B (de) | 1998-09-15 | 2002-01-25 | Immuno Ag | Neue influenzavirus-impfstoffzusammensetzung |
| EP2204186B1 (de) * | 1999-02-17 | 2016-04-06 | CSL Limited | Immunogene Komplexe und damit zusammenhängende Verfahren |
| DE10007771A1 (de) * | 2000-02-14 | 2001-08-23 | Kleine & Steube Entoxin Gmbh | Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US6471968B1 (en) | 2000-05-12 | 2002-10-29 | Regents Of The University Of Michigan | Multifunctional nanodevice platform |
| US7785610B2 (en) * | 2001-06-21 | 2010-08-31 | Dynavax Technologies Corporation | Chimeric immunomodulatory compounds and methods of using the same—III |
| US20030199466A1 (en) * | 2001-06-21 | 2003-10-23 | Fearon Karen L. | Chimeric immunomodulatory compounds and methods of using the same - ll |
| US20040087564A1 (en) * | 2002-10-31 | 2004-05-06 | Wright D. Craig | Delivery composition and method |
| EP1796537A4 (de) * | 2004-08-25 | 2012-03-07 | Univ Michigan | Dendrimer-basierte zusammensetzungen und verfahren zu ihrer verwendung |
| US20070041934A1 (en) * | 2005-08-12 | 2007-02-22 | Regents Of The University Of Michigan | Dendrimer based compositions and methods of using the same |
| US8652782B2 (en) | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
| US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
| US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| EP2137656A2 (de) * | 2007-04-19 | 2009-12-30 | The Regents of the University of Michigan | Dendrimer-basierte zusammensetzungen und verfahren zu ihrer verwendung |
| WO2008151389A1 (en) * | 2007-06-15 | 2008-12-18 | Macfarlane Burnet Institute For Medical Research And Public Health Limited | Chemically modified macromolecules |
| US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
| US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
| US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| AU2008293504B2 (en) | 2007-08-27 | 2012-04-12 | Longhorn Vaccines & Diagnostics, Llc | Immunogenic compositions and methods |
| US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
| AU2008343745B2 (en) | 2007-10-01 | 2012-05-10 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection and transport system and methods of use |
| US8252834B2 (en) | 2008-03-12 | 2012-08-28 | The Regents Of The University Of Michigan | Dendrimer conjugates |
| WO2010039861A2 (en) | 2008-09-30 | 2010-04-08 | The Regents Of The University Of Michigan | Dendrimer conjugates |
| US9017644B2 (en) | 2008-11-07 | 2015-04-28 | The Regents Of The University Of Michigan | Methods of treating autoimmune disorders and/or inflammatory disorders |
| EP3611270B1 (de) | 2009-05-19 | 2021-12-01 | University Of Miami | Kits zur in-vitro-antigen-darstellung, zur überprüfung der wirksamkeit eines impfstoffs und zur überprüfung der immuntoxizität von biologischen stoffen und arzneimitteln |
| CN102917699A (zh) | 2009-10-13 | 2013-02-06 | 密执安大学评议会 | 树枝状聚合物组合物和合成方法 |
| US8912323B2 (en) | 2009-10-30 | 2014-12-16 | The Regents Of The University Of Michigan | Multifunctional small molecules |
| EP2778221B1 (de) | 2011-02-07 | 2017-07-26 | Life Technologies Corporation | Zusammensetzungen und Verfahren zur Stabilisierung von empfindlichen Verbindungen |
| US9402911B2 (en) | 2011-12-08 | 2016-08-02 | The Regents Of The University Of Michigan | Multifunctional small molecules |
| CA2863083C (en) | 2012-01-26 | 2023-09-19 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| CN103951630B (zh) * | 2014-04-17 | 2016-06-01 | 华南农业大学 | 一种直接检测呋喃它酮代谢物amoz的树状半抗原、树状抗原及其应用 |
| US9976136B2 (en) | 2015-05-14 | 2018-05-22 | Longhorn Vaccines And Diagnostics, Llc | Rapid methods for the extraction of nucleic acids from biological samples |
| US9821055B2 (en) * | 2015-11-07 | 2017-11-21 | Purdue Research Foundation | Vaccine adjuvants |
| WO2021046307A1 (en) * | 2019-09-04 | 2021-03-11 | North Carolina State University | Hybridized poly(amidoamine)-amino acid dendrimers |
| US11904006B2 (en) | 2019-12-11 | 2024-02-20 | University Of Iowa Research Foundation | Poly(diaminosulfide) particle-based vaccine |
| US12485166B2 (en) | 2020-02-06 | 2025-12-02 | Longhorn Vaccines And Diagnostics, Llc | Vaccines for the treatment and prevention of zoonotic infections |
| US20220040315A1 (en) * | 2020-08-09 | 2022-02-10 | Fulu Labs Corporation | Nuclease-dendrimer formulations for covid-19 and broad-spectrum antiviral therapy and prophylaxis |
| US20230293678A1 (en) * | 2020-08-21 | 2023-09-21 | Aliasger K. Salem | Cationic nanoparticle adjuvants |
| GB2700078A (en) | 2020-10-20 | 2025-09-17 | Longhorn Vaccines & Diagnostics Llc | Immunogenic antigens |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4587329A (en) * | 1984-08-17 | 1986-05-06 | The Dow Chemical Company | Dense star polymers having two dimensional molecular diameter |
| US5338532A (en) * | 1986-08-18 | 1994-08-16 | The Dow Chemical Company | Starburst conjugates |
| WO1993022343A1 (en) * | 1992-05-01 | 1993-11-11 | The Rockfeller University | Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom |
| US5482698A (en) * | 1993-04-22 | 1996-01-09 | Immunomedics, Inc. | Detection and therapy of lesions with biotin/avidin polymer conjugates |
| US5561043A (en) * | 1994-01-31 | 1996-10-01 | Trustees Of Boston University | Self-assembling multimeric nucleic acid constructs |
| AUPM623994A0 (en) * | 1994-06-15 | 1994-07-07 | Biomolecular Research Institute Limited | Antiviral dendrimers |
-
1996
- 1996-02-07 US US08/597,938 patent/US5795582A/en not_active Expired - Fee Related
-
1997
- 1997-02-06 JP JP9528602A patent/JP2000507921A/ja not_active Ceased
- 1997-02-06 DE DE69733652T patent/DE69733652D1/de not_active Expired - Lifetime
- 1997-02-06 WO PCT/US1997/001664 patent/WO1997028809A1/en not_active Ceased
- 1997-02-06 EP EP97904184A patent/EP0914134B1/de not_active Expired - Lifetime
- 1997-02-06 AU AU18541/97A patent/AU1854197A/en not_active Abandoned
- 1997-02-06 AT AT97904184T patent/ATE298580T1/de not_active IP Right Cessation
- 1997-02-06 CA CA002249544A patent/CA2249544A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US5795582A (en) | 1998-08-18 |
| EP0914134B1 (de) | 2005-06-29 |
| EP0914134A4 (de) | 2000-10-18 |
| WO1997028809A1 (en) | 1997-08-14 |
| JP2000507921A (ja) | 2000-06-27 |
| EP0914134A1 (de) | 1999-05-12 |
| DE69733652D1 (de) | 2005-08-04 |
| CA2249544A1 (en) | 1997-08-14 |
| AU1854197A (en) | 1997-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE298580T1 (de) | Eigenschaften von poly(amidoamine) dendrimeren als adjuvantien | |
| NO20011282D0 (no) | Nytt influensavirusvaksinepreparat | |
| PT840791E (pt) | Desenvolvimento de respostas imunitarias para antigenios especificos da prostata (psa) | |
| ATE315405T1 (de) | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung | |
| DK1459766T3 (da) | Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner | |
| CY1111372T1 (el) | Ανοσολογικη συνθεση και εμβολια που περιεχουν ν-φορμυλομεθειονυλο πεπτιδιο ως ανοσοενισχυτικο | |
| ATE422352T1 (de) | Liposomaler grippeimpfstoff und verfahren | |
| DE69937571D1 (de) | Mutiertes cholera holotoxin als hilfsmittel | |
| AUPR011700A0 (en) | Composition comprising immunogenic virus sized particles (VSP) | |
| CY1115778T1 (el) | Πολλαπλες παραλλαγες της πρωτεϊνης μηνiγγιτιδοκοκκου νμβ1870 | |
| AU2002355677A1 (en) | Antigenic polypeptides | |
| CY1105963T1 (el) | Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης | |
| ATE263189T1 (de) | Antikörper gegen menschliches prostatspezifisches drüsenkallikrein | |
| EA199900069A1 (ru) | Вакцинная композиция против малярии | |
| CY1112658T1 (el) | Εμβολια τα οποια περιεχουν αντιγονο μαgε συνδεομενο με θραυσμα πρωτεϊνης d | |
| CY1105600T1 (el) | Κατασκευασματα νουκλεϊκων οξεων για γενετικη ανοσοποιηση | |
| DE60222296D1 (de) | Impfstoff von umhüllten viren und verfahren zu seiner herstellung | |
| NL300336I2 (nl) | Vaccin tegen de bof dat een jeryl-lynn virusstam bevat | |
| DE60220642D1 (de) | Perylenequinone zur anwendung mit immunotherapeutischen mitteln | |
| ES2059305T5 (es) | Proteina del virus de la seudorrabia. | |
| DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung | |
| WO2003006055A8 (en) | Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit | |
| ATE345812T1 (de) | Antigen-mimotope und vakzine gegen krebserkrankungen | |
| ATE374622T1 (de) | Genetische impstoffe mit adjuvans | |
| DE60036705D1 (de) | Adjuvanskombinationen zur immunisierung und vakzine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |